MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.

MicroRNAs (miRs) are a class of small non-coding RNAs that are involved in the regulation of gene expression, and in cancer development and progression. In the present study, miR-320 expression was found to be significantly reduced in glioma tissue in comparison with that in adjacent healthy tissues. In the present study, in vitro analyses demonstrated that overexpression of miR-320 inhibited cell proliferation and metastasis, while antisense miR-320 oligonucleotides enhanced cell proliferation and migration in U251 and SHG-44 glioma cell lines, compared with that in negative control cells. Protein expression of E2F1, a cell-cycle regulator, was negatively regulated by miR-320. Therefore, the present study provides novel insights into the association between miR-320 and glioma development.

MicroRNA-181 inhibits glioma cell proliferation by targeting cyclin B1.

Small non­coding RNAs from the microRNA family (miRs) are important elements in the posttranscriptional control of gene expression. miRs are known to regulate numerous cellular processes and are of crucial importance during development and in pathological conditions, including tumor initiation and progression. In the present study, the expression level of miR­181 was reduced in glioma tissues compared with the adjacent normal tissues. The enforced expression of miR­181 was able to inhibit cell proliferation in U251 and SHG­44 cells, while antisense miR­181 oligonucleotides (antisense miR­181) enhanced cell proliferation. At the molecular level, these results further revealed that the expression of cyclin B1, a positive cell­cycle regulator, was negatively regulated by miR­181. Therefore, the data reported in the present study demonstrates that miR­181 is an important regulator in glioma. These results may contribute to improving the understanding of the key misregulated miRNAs in glioma.

Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.

We conducted a meta-analysis in order to investigate the relationships between PTEN gene mutations and the prognosis in glioma. The following electronic databases were searched for relevant articles without any language restrictions: Web of Science (1945 ~ 2013), the Cochrane Library Database (Issue 12, 2013), PubMed (1966 ~ 2013), EMBASE (1980 ~ 2013), CINAHL (1982 ~ 2013), and the Chinese Biomedical Database (CBM) (1982 ~ 2013). Meta-analyses were conducted using the STATA software (Version 12.0, Stata Corporation, College Station, Texas USA). Hazard ratio (HR) with its corresponding 95 % confidence interval (95%CI) was calculated. Six independent cohort studies with a total of 357 glioma patients met our inclusion criteria. Our meta-analysis results indicated that glioma patients with PTEN gene mutations exhibited a significantly shorter overall survival (OS) than those without PTEN gene mutations (HR = 3.66, 95%CI = 2.02 ~ 5.30, P < 0.001). Ethnicity-stratified subgroup analysis demonstrated that PTEN gene mutations were closely linked to poor prognosis in glioma among Americans (HR = 3.72, 95%CI = 1.72 ~ 5.73, P < 0.001), while similar correlations were not observed among populations in Sweden, Italy, and Malaysia (all P > 0.05). Our meta-analysis provides direct and strong evidences for the speculation of PTEN gene mutations' correlation with poor prognosis of glioma patients.

Endoscopic expand transnasal approach to the suprasellar region: anatomical study and clinical considerations.

BACKGROUND: The expanded endonasal approach (EEA) is used sparingly by surgeons for resection of lesions in the ventrocranial base. Herein, we examined the anatomy of the ventrocranial base by endoscopy and comment on the use of EEA in clinical practice. METHODS: Twenty artery-injected adult cadaveric heads were studied under surgical conditions using the endoscopic EEA. The extent of the surgical exposure, the endoscopic anatomic view and the maneuverability of surgical instruments about the suprasellar region were studied by the endoscopic EEA. RESULTS: The EEA by endoscope can reach the suprasellar region. In this approach, the optocarotid recess, supra and infra-optic chiasm interspace, the ophthalmic artery and others were important anatomical landmarks for identification of the suprasellar region. CONCLUSIONS: The endoscopic EEA can be used to remove many types of lesions in the ventrocranial base. The microanatomy observed using the endoscope provides important anatomical information on the suprasellar region for neurosurgeons.

[Experiments of micro-distance measurement for GMLM with spectrum analysis method].

Projection display devices are undergoing a period of multi-development, and with the maturation of MEMS technology, which leads to MEMS-based light modulators for display applications, have become one of the research focuses. The structure of MEMS-based grating moving light modulator (GMLM) is composed of the reflection plate, address electrode and four cantilevers, and movable grating plate, which is supported by four crab-cantilevers placed around, and is actuated like a piston by electrostatic force. The piston-type motion of grating can be used to modulate the phase of incident light. The micro-distance between the upper surface of movable grating and underlying reflector is a key parameter and is important to GMLM performance. Traditional measurement method such as step-machine would destroy the device; while a high accuracy and non-contact measurement machine called KYKO White Light Interferometer is expensive. In the present paper, the GMLM optical principle using scalar diffraction theory was in details analyzed. A novel non-contact wavelength scanning spectrum analysis method was put forward to measure the distance between the upper surface of movable grating and underlying reflector. The U-4100 spectrophotometer was adopted to gain spectrum information; while the spectrum analysis method using peak wavelength position was introduced to calculate the micro distance. The measurement result is consistent to theoretical result. The micro-distance is 1.131 3 microm using such non-contact wavelength scanning spectrum analysis method, while it is 1.240 0 microm with WYKO White Light Interferometer. The relative error was lower than 1%, compared with the results measured by WYKO White Light Interferometer, and the method has good repetition ability and is cheap with RMB50 Yuan each time. Furthermore, measuring pull-in voltage, resonance frequency and micro distance in MEMS-based diffraction and interference devices was proposed completely based on such non-contact wavelength scanning spectrum analysis method.

[Establishment of malignant progression associated gene expression profiles in human brain glioma].

OBJECTIVE: To establish malignant progression associated gene expression profiles in human brain glioma. METHODS: The primary (WHO grade II), recurrent (WHO grade III) and re-recurrent (WHO grade IV) glioma specimens were sequentially collected from one single patient. Gene expression of different tumor specimens and normal brain tissue of the same patient was compared by microarrary techniques. RESULTS: 197 differentially expressed genes with differential ratio > or = 3 were observed when compared with normal brain tissue. When the specimens (3 tumor, 1 normal brain) were paired with each other, 7 groups containing 489 genes (upregulated 193, downregulated 296) were observed. According to the descending frequency of the 109 genes with known function, they were the genes associated with development, metabolism, differentiation, signal transduction, DNA binding transcription, cellular receptor, immunity, ion-channel transportation, protein translation, cell backbone motion, stress, protooncogene and anti-oncogene and cell apoptosis, respectively. CONCLUSION: From the 197 differentially expressed genes found in one glioma patient experiencing tumor malignant progression, 17 genes screened out by bioinformatics assay, may offer valuable information on molecular mechanisms on genesis and malignant progression of glioma.

[Bioinformatic analysis of glioma development relative genes].

BACKGROUND & OBJECTIVE: Exploiting the transcriptional regulation mechanism by microarray and bioinformatics is an important method at genomic research field, and it is better than previous methods, by which we can easily analyze the gene expression regulative networks at genomic level. This study was designed to analyze the glioma gene expression profiles by clustering and bioinformatic retrieving to seek some tumor development relative genes that can be cloned for the purpose of function research in the future. METHODS: Firstly, we analyzed the glioma gene expression profiles of 16,363 genes by clustering, and chose 368 genes which expression differences were greater than 2 folds and the variances of 2 dots were smaller than 0.33. We selected 2 groups of genes that were expressed similarly. One group (11 cases) was upregulated with the glioma development and another (6 cases) was downregulated with the glioma development. Secondly, we determined the genomic information about those 17 genes and exploited their association with the development of gliomas. RESULTS: Two groups of genes were expressed similarly during the glioma development, one group was upregulated with the development of gliomas, and another was downregulated. Bioinformatic analysis showed that 3 of those genes (X55987, M85085, and AB011097) might be important tumor relative genes. CONCLUSION: By bioinformatics and microarray technologies, we found 3 genes, X55987(EDN, eosinophil-derived neurotoxin), AB011097 (ARTS-1, TNF receptor shedding regulator),and M85085(CStF, cleavage stimulation factor), which might be potential key tumor development relative genes that can be developed for therapy targets in the future.